NOV 15, 2018 1:29 PM PST

Making Cancer Disappear?

WRITTEN BY: Nouran Amin

Neuroblastoma is one of the most common childhood cancers and the leading cause of cancer deaths among pediatric patients younger than 5. The cancer is frequently found in the adrenal glands on top of the kidneys. Despite intensive treatment regimens, survival rates are 50%.

Most recently, researchers investigating new treatments found a combination of two drugs that made the tumors ‘disappear’ in a mouse model.

"To study neuroblastoma in the laboratory, we use a genetically modified neuroblastoma mouse model that closely recapitulates clinical features of the disease, and these mice spontaneously develop neuroblastomas within weeks after birth,” says Professor Murray Norris, deputy director of the Children's Cancer Institute Australia for Medical Research.

The combination of drugs are CBL0137, which belong to curaxins—that attack the structure of cancer cells and the second is panobinostat. The FDA has approved panobinostat previously for Melanoma and is being tested for other cancers. Additionally, CBL0137 is currently undergoing the approval process for phase I clinical trials in adults.

Credit: University of Minnesota, ‘‘Dirty’ Mice May Be Better Models of Human Biology”

“We have found that when we combined CBL0137 and panobinostat to treat mice bearing neuroblastomas, the tumors disappeared and never came back during the entire experiment, whereas the tumors continued to grow in mice that received either no treatment or only single drug treatment. This is a highly significant finding as this drug combination is the most effective therapy that we have observed in this neuroblastoma mouse model. It is unusual to see this effect, especially in these mice where neuroblastoma develops within seven weeks of birth and is aggressive in nature. In fact, the CBL0137/panobinostat combination is more effective than any other current clinical chemotherapy combinations that our laboratory has tested in these mice,” says Prof. Norris.

To specifically detect the drug-induced changes in the tumors, researchers used RNA sequencing technology to examine how the drug combination was effective enough in eliminating the neuroblastoma.

"Our results suggest that these drugs work through two different mechanisms that offer a two-pronged attack. One of these mechanisms appears to be a direct attack on the cancer cells themselves, killing them by inhibiting DNA repair; then a second mechanism is involved in inducing a robust immune response. This is very exciting and will hopefully facilitate the clinical development of effective and non-toxic therapies for childhood cancer," explains Prof. Norris.

Researchers are hopeful to continue their investigation to show how the drugs activate immune responses, slow the growth of aggressive childhood leukemia, and to test CBL0137/panobinostat with other immunotherapy drugs in mice.

Source: ScienceDaily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 11, 2019
Neuroscience
NOV 11, 2019
The Women Who Can Smell Without Olfactory Bulbs
Until now, it has been commonly accepted that our sense of smell depends on the transmission of olfactory information from the nose to the olfactory bulb i...
NOV 19, 2019
Cannabis Sciences
NOV 19, 2019
Cannabis Can't Simply Replace Opioids for Pain Management
According to the research, cannabis is not effective when it comes to treating individuals struggling with opioid use disorder. While some may have conside...
JAN 16, 2020
Cancer
JAN 16, 2020
FLASH proton therapy: faster and more effective
A new technique called FLASH proposes a new type of radiation therapy. The technique is composed of an ultra-high dose rate of radiotherapy and uses electr...
JAN 23, 2020
Cell & Molecular Biology
JAN 23, 2020
Scientists Engineer Venom-Producing Organoids
Snake venom is also a source of therapeutics, and a potential source of new medicines....
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
China Begins Trials for Antiviral Drug to Tackle Coronavirus
So far, coronavirus has infected over 31,493 people globally, and has killed 638. Although 1,563 people have reportedly recovered, due to its fast-spreadin...
FEB 08, 2020
Cancer
FEB 08, 2020
Magic mushrooms help cancer patients' depression
A follow-up to a study originally published in the Journal of Psychopharmacology in 2016 reports the long-term benefits of a one-time, single-dose tre...
Loading Comments...